A subarachnoid hemorrhage (SAH) is bleeding in the space between the brain and the surrounding membrane (subarachnoid space), causing a sudden and severe headache. Bleeding that results from the rupture of an abnormal bulge in a blood vessel (aneurysm) in the brain are known as Aneurysmal Subarachnoid Hemorrhage (aSAH).&nbsp;
&nbsp;
Most spontaneous SAHs result from the rupture of intracranial aneurysms; therefore, risk factors for aneurysm formation overlap with risk factors for SAH such as smoking, hypertension, alcohol abuse, genetic risk, and others.
&nbsp;
Aneurysmal Subarachnoid Hemorrhage Epidemiological Segmentation&nbsp;
The Epidemiological Segmentation of Aneurysmal Subarachnoid Hemorrhage in 7MM from 2017 to 2030 is segmented as:-&nbsp;
<ul>
<li>Incidence of Subarachnoid Hemorrhage (SAH)</li>
<li>Diagnosed Incidence of aSAH</li>
<li>Age-specific Incidence of aSAH&nbsp;</li>
<li>WFNS Grade-wise segmentation of aSAH</li>
<li>Fisher Grade-wise segmentation of aSAH&nbsp;</li>
<li>Clinical Manifestations of aSAH&nbsp;&nbsp;</li>
</ul>
&nbsp;
Aneurysmal Subarachnoid Hemorrhage Epidemiology&nbsp;
<ul>
<li>The total incident cases of Aneurysmal Subarachnoid Hemorrhage in 7MM were 53,611 in 2017.</li>
<li>The incident population of Aneurysmal Subarachnoid Hemorrhage in Japan in 2017 was 33,277.&nbsp;</li>
</ul>
&nbsp;
<a style="color: #0066cc;" href="https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-market" target="_blank" rel="noopener noreferrer">Aneurysmal Subarachnoid Hemorrhage Market</a>
Market Size of aSAH in 7MM in 2017 was USD 155.47 Million&nbsp;&nbsp;
&nbsp;
Aneurysmal Subarachnoid Hemorrhage Market Drivers
<ul>
<li>Strengthening of the molecular basis of SAH</li>
<li>New potential targets for therapeutics development</li>
</ul>
&nbsp;
Aneurysmal Subarachnoid Hemorrhage Market Barriers
<ul>
<li>Limited number of upcoming therapies&nbsp;</li>
<li>Lack of clarity in disease understanding</li>
<li>Lack of in-depth pathogenesis&nbsp;</li>
<li>Expensive diagnosis procedures</li>
</ul>
&nbsp;
Aneurysmal Subarachnoid Hemorrhage Emerging Drugs
The emerging&nbsp;drugs of the Aneurysmal Subarachnoid Hemorrhage market are&nbsp;
<ul>
<li>SFX-01</li>
<li>Clazosentan</li>
<li>GTX-104</li>
<li>EG-1962</li>
<li>Nicaplant (nicardipine)</li>
</ul>
And many others.&nbsp;
&nbsp;
Aneurysmal Subarachnoid Hemorrhage Key Players
The key players in the Aneurysmal Subarachnoid Hemorrhage market are
<ul>
<li>Evgen Pharma</li>
<li>Idorsia Pharmaceuticals</li>
<li>Grace Therapeutics</li>
<li>Edge Therapeutics/PDS Biotechnology Corporation</li>
<li>BIT Pharma</li>
</ul>
And many others.&nbsp;

Aneurysmal Subarachnoid Hemorrhage Market

Aneurysmal Subarachnoid Hemorrhage Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.